Nuvation Bio Inc. (NUVB) Tops Q2 EPS by 2c

Nuvation Bio Inc. (NYSE: NUVB) reported Q2 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.

You May Also Be Interested In

• Boyd Group Services Inc. (BGSI) Misses Q2 EPS by 19c
• Mount Logan Capital Inc. (MLCI) Reports Q2 Loss of $0.37
• Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c